Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Non melanoma skin cancer, Skin cancer
Closed
Other
This trial is looking at how sorafenib (Nexavar) works in schwannomas of the skin.
Skin schwannomas are non cancerous () tumours that may develop on the skin of people who have a condition called type 2 (NF 2). NF 2 is a condition that is caused by changes in the in the body’s cells. People with NF 2 have an increased risk of developing certain types of tumours. Neurofibromatosis is difficult to treat and doctors are looking for new ways to manage it.
Recruitment start: 1 December 2011
Recruitment end: 1 March 2017
Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.
Professor Oliver Hanemann
NIHR Clinical Research Network: Cancer
University Hospitals Plymouth NHS Trust
The Brain Tumour Charity
Last reviewed: 24 Jan 2019
CRUK internal database number: 8654

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.